Bullish Case: Known: NRGV at $3.79 with call volume far above puts; IV remains high but the NRGV term structure is nearly flat (mid-curve dip, then re-rising). Inferred from the IV surface: relatively weak strike skew → market doubts a persistent crash. If the next update (likely by the Aug 21 expiry) confirms backlog-to-revenue and margin/EBITDA progress, price could rebound ~toward mid-$4s while IV compresses. My earlier “beat/raise” scenario fits best.

Bearish Case: Known: short-term trend is down (week -15%, month -27%); near-dated IV is extreme (e.g., Jul 17 calls ~145–156%). Inferred: NRGV return surface shows highest likelihood around modest outcomes, while large positive tails are thin. Uncertain: whether backlog fails to convert or financing/dilution reappears. My earlier “miss/guide down” execution-delay story fits this weakness; that would likely trigger a downside gap and keep IV elevated, especially if SPY IV rises.

Potential Outcomes:

1. 20%: backlog conversion + cash burn improves; NRGV trend up into Aug21; IV compresses; close >$4.70.
2. 40%: in-line quarter but dilution persists; choppy -10% to +10%; IV mean-reverts.
3. 25%: revenue recognition/margins miss or financing headline; put IV spikes; -30% to -50%.
4. 10%: SPY risk-off drives correlational selloff; -15% to -25%.
5. 5%: social/flow squeeze; +40% spike then fade.

July 08, 2026